English

SIGNPATH PHARMA, INC.

EDGAR

SGTH Quarterly report (10-Q) · filed 2016-08-15

33 filing records in this dataset, filed from 2009-04-07 to 2016-08-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-211 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -569259 USD Source
Operating Cash Flow: -358041 USD Source

Free cash flow

-211 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -569259 USD Source
Operating Cash Flow: -358041 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 1.34 million USD 2013-09-30 Source
Exact value

1342792 USD
Long-term debt including current maturities: Not available
Shares outstanding: 14.2 million shares 2016-06-30 Source
Exact value

14203887 shares

Reported share-count change

0.28% · 40 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

14163887 shares · 2015-06-30· Source
14203887 shares · 2016-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 0 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 0 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 0 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 0 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 0 USD · 2011-07-01 – 2011-09-30 Source

Net income

-1.83 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Net income: -477096 USD · 2015-07-01 – 2015-09-30 Source
Net income: -1634990 USD · 2015-01-01 – 2015-12-31 Source
Net income: -1363242 USD · 2015-01-01 – 2015-09-30 Source
Net income: -394082 USD · 2016-01-01 – 2016-03-31 Source
Net income: -685575 USD · 2016-04-01 – 2016-06-30 Source

Operating cash flow

-1.15 million USD

2015-07-01 – 2016-06-30

Exact inputs and evidence

Operating cash flow: -1291831 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -851207 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -1494151 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -1291831 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -231411 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -503201 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -231411 USD · 2016-01-01 – 2016-03-31 Source

Capital expenditure

0 USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Capital expenditure: 1390 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 1390 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 0 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 0 USD · 2011-01-01 – 2011-06-30 Source
Capital expenditure: 0 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 0 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 0 USD · 2011-01-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-08-15.

Financial data available through: 2015-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2010-12-31
Operating income: 8 of 11 periods available· newest 2015-12-31
Net income: 9 of 11 periods available· newest 2015-12-31
Operating cash flow: 8 of 11 periods available· newest 2015-12-31
Capital expenditure: 3 of 11 periods available· newest 2010-12-31
Total assets: 8 of 11 periods available· newest 2015-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2015-12-31
Current liabilities: 8 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 1.11 million

Prior period

−USD 2.75 million

2014-01-01 – 2014-12-31
Current period

−USD 1.63 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-1634990 − -2748190 = 1113200 USD

-2748190 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-1634990 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SIGNPATH PHARMA, INC. · 2015-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Year-over-year change in Net income: 1113200 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1634990 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#90679 Filing: 000149315216008758 Input fundies:NetIncome: -2748190 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#90785 Filing: 000149315216008758
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 681,813

Prior period

−USD 2.18 million

2014-01-01 – 2014-12-31
Current period

−USD 1.49 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-1494151 − -2175964 = 681813 USD

-2175964 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-1494151 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SIGNPATH PHARMA, INC. · 2015-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Year-over-year change in Operating cash flow: 681813 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1494151 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#81065 Filing: 000149315216008758 Input fundies:OperatingCashFlow: -2175964 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#81229 Filing: 000149315216008758
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 0
Operating costs Derived USD 1.62 million
Operating income −USD 1.62 million
Tax, interest and other Derived USD 497,227
Net income −USD 2.12 million

Cash

Operating cash flow −USD 698,325
Capital expenditure USD 1,390
Free cash flow Derived −USD 699,715

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2008 2008-01-01 – 2008-12-31	1631771 Derived	-1631771	63995 Derived	-1695766	-745653 Derived	Source 2008-01-01 – 2008-12-31: 0 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -1631771 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -1695766 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -745653 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	612098 Derived	-612098	118645 Derived	-730743	-529556 Derived	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -612098 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -730743 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -529556 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	1621832 Derived	-1621832	497227 Derived	-2119059	-699715 Derived	Source 2010-01-01 – 2010-12-31: 0 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -1621832 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -2119059 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -698325 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 1390 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2010

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20082008-12-31	Revenue	Revenue: 0 Open source
20092009-12-31	Revenue	Revenue: 0 Open source
20102010-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20102010-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Operating margin	Not reported	Operating Income: -1631771 Open source Revenue: 0 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -612098 Open source Revenue: 0 Open source
20102010-12-31	Operating margin	Not reported	Operating Income: -1621832 Open source Revenue: 0 Open source
20082008-12-31	Net margin	Not reported	Net Income: -1695766 Open source Revenue: 0 Open source
20092009-12-31	Net margin	Not reported	Net Income: -730743 Open source Revenue: 0 Open source
20102010-12-31	Net margin	Not reported	Net Income: -2119059 Open source Revenue: 0 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -745653 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -529556 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -698325 Open source Capital Expenditure: 1390 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -698.3K 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	-745653	Operating Cash Flow: -745653 Open source
20092009-12-31	Operating cash flow	-529556	Operating Cash Flow: -529556 Open source
20102010-12-31	Operating cash flow	-698325	Operating Cash Flow: -698325 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -699.7K 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	-745653	Operating Cash Flow: -745653 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow	-529556	Operating Cash Flow: -529556 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow	-699715	Operating Cash Flow: -698325 Open source Capital Expenditure: 1390 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Liabilities / assets	Not reported	Total Assets: 184328 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 297818 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 51666 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.01× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	2.35×	Current Assets: 181128 Open source Current Liabilities: 76999 Open source
20092009-12-31	Current assets / current liabilities	0.1×	Current Assets: 295418 Open source Current Liabilities: 2942570 Open source
20102010-12-31	Current assets / current liabilities	0.01×	Current Assets: 48993 Open source Current Liabilities: 4452822 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2007-01-01 – 2007-12-31	−USD 526,833 Exact value Exact value: -526833 USD 2007-01-01 – 2007-12-31: -526833 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2007-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -526833 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -526833 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#21385 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 1.7 million Exact value Exact value: -1695766 USD 2008-01-01 – 2008-12-31: -1695766 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2008-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -1695766 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1695766 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#25025 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	−USD 745,653 Exact value Exact value: -745653 USD 2008-01-01 – 2008-12-31: -745653 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2008-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -745653 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -745653 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-10-020599.txt#10959 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGNPATH PHARMA, INC. · 2008-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-10-020599.txt#11027 The citation records this snapshot. The page link may show a newer release later.	−USD 745,653 Calculation and evidence -745653 − 0 USD Exact free cash flow: -745653 USD 2008-01-01 – 2008-12-31: -745653 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGNPATH PHARMA, INC. · 2008-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Free cash flow: -745653 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -745653 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-10-020599.txt#10959 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-10-020599.txt#11027 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 730,743 Exact value Exact value: -730743 USD 2009-01-01 – 2009-12-31: -730743 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2009-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -730743 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -730743 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#27797 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	−USD 529,556 Exact value Exact value: -529556 USD 2009-01-01 – 2009-12-31: -529556 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2009-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -529556 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -529556 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-11-018135.txt#7436 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGNPATH PHARMA, INC. · 2009-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-11-018135.txt#7482 The citation records this snapshot. The page link may show a newer release later.	−USD 529,556 Calculation and evidence -529556 − 0 USD Exact free cash flow: -529556 USD 2009-01-01 – 2009-12-31: -529556 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGNPATH PHARMA, INC. · 2009-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Free cash flow: -529556 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -529556 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-11-018135.txt#7436 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/0001144204-11-018135.txt#7482 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 2.12 million Exact value Exact value: -2119059 USD 2010-01-01 – 2010-12-31: -2119059 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2010-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -2119059 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2119059 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#31841 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	−USD 698,325 Exact value Exact value: -698325 USD 2010-01-01 – 2010-12-31: -698325 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2010-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -698325 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -698325 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690612000735/sppxbrl-20111231.xml#16026 Filing: 000109690612000735 The citation records this snapshot. The page link may show a newer release later.	USD 1,390 Exact value Exact value: 1390 USD 2010-01-01 – 2010-12-31: 1390 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SIGNPATH PHARMA, INC. · 2010-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Capital Expenditure: 1390 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1390 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690612000735/sppxbrl-20111231.xml#16358 Filing: 000109690612000735 The citation records this snapshot. The page link may show a newer release later.	−USD 699,715 Calculation and evidence -698325 − 1390 USD Exact free cash flow: -699715 USD 2010-01-01 – 2010-12-31: -698325 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 1390 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SIGNPATH PHARMA, INC. · 2010-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Free cash flow: -699715 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -698325 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690612000735/sppxbrl-20111231.xml#16026 Filing: 000109690612000735 Input fundies:CapitalExpenditure: 1390 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690612000735/sppxbrl-20111231.xml#16358 Filing: 000109690612000735 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 2.28 million Exact value Exact value: -2284393 USD 2011-01-01 – 2011-12-31: -2284393 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2011-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -2284393 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2284393 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#35642 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	−USD 1.21 million Exact value Exact value: -1209103 USD 2011-01-01 – 2011-12-31: -1209103 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2011-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -1209103 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1209103 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690613000421/sppxbrl-20121231.xml#79883 Filing: 000109690613000421 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 1.31 million Exact value Exact value: -1310934 USD 2012-01-01 – 2012-12-31: -1310934 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2012-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -1310934 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1310934 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#44008 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	−USD 883,328 Exact value Exact value: -883328 USD 2012-01-01 – 2012-12-31: -883328 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2012-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -883328 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -883328 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690614001111/sppxbrl-20140331.xml#48428 Filing: 000109690614001111 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 1.96 million Exact value Exact value: -1956872 USD 2013-01-01 – 2013-12-31: -1956872 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2013-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -1956872 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1956872 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690615000373/sppxbrl-20141231.xml#17444 Filing: 000109690615000373 The citation records this snapshot. The page link may show a newer release later.	−USD 1.62 million Exact value Exact value: -1620199 USD 2013-01-01 – 2013-12-31: -1620199 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2013-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -1620199 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1620199 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000109690615000373/sppxbrl-20141231.xml#18869 Filing: 000109690615000373 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 2.75 million Exact value Exact value: -2748190 USD 2014-01-01 – 2014-12-31: -2748190 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2014-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -2748190 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2748190 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#90785 Filing: 000149315216008758 The citation records this snapshot. The page link may show a newer release later.	−USD 2.18 million Exact value Exact value: -2175964 USD 2014-01-01 – 2014-12-31: -2175964 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2014-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -2175964 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2175964 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#81229 Filing: 000149315216008758 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 1.63 million Exact value Exact value: -1634990 USD 2015-01-01 – 2015-12-31: -1634990 USD Inspect Net Income Open source Share or cite Citation for Net Income · SIGNPATH PHARMA, INC. · 2015-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Net Income: -1634990 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1634990 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#90679 Filing: 000149315216008758 The citation records this snapshot. The page link may show a newer release later.	−USD 1.49 million Exact value Exact value: -1494151 USD 2015-01-01 – 2015-12-31: -1494151 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SIGNPATH PHARMA, INC. · 2015-12-31 SIGNPATH PHARMA, INC. (edgar:1455694) Operating Cash Flow: -1494151 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:13:43Z Snapshot: 4d4040b8db45d307711b08151ec034604dacf22c9a21de97a66432326d2e9b97 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455694/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1494151 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455694/000149315216008758/sgth-20151231.xml#81065 Filing: 000149315216008758 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

33 filings · 1,039 latest values · 1,039 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001455694, 1455694, SGTH, edgar:1455694

Also known as SIGNPATH PHARMA, INC., SignPath Pharma, Inc.

SIGNPATH PHARMA, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation